← back to database
Decheng Capital is a global life-sciences and healthcare investment firm backing early-stage scientific innovation and growth-stage healthcare companies across biopharma, diagnostics, tools, medical devices and services. It reports more than $2.5 billion in assets under management.
Stage focus
Specialization
Generalist / Specialist
Specialist
Latest fund size
$2.5B+ AUM
Investing team
Aaron LiPrincipal
Claire ZhangSenior Associate
Dayton MisfeldtPartner
Joan ChenVice President
Michael NotarasVice President
Min CuiFounder & Managing Director
Peter ColabuonoManaging Director
Qiang XuPartner
Shengyang JinVice President
Tony TongPartner
Victor Tong Jr.Managing Director
Wei XuPartner